RESEARCH-USE BIOSIMILAR ANTIBODY
Pateclizumab
Monoclonal antibody · IgG1
Pateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis.
TARGETLTA
YMonoclonal antibody
CATALOGSC-BS-288
CATALOG NUMBERSC-BS-288
MOLECULAR WEIGHTApprox. 144.9 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Pateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis.
Pateclizumab is a recombinant research-use antibody directed against LTA.